// CANCER TRIALS
Cancer Trial Recruitment
Cancer is a global health challenge that affects millions of people each year. To combat this, clinical trials are a vital step in the discovery of new treatments and therapies. These trials provide the scientific data needed to determine whether new treatments are safe, effective, and better than the current standard of care.
There are numerous challenges associated with cancer trial recruitment.
Many patients are unaware of available trials, while others may be hesitant due to the perceived risks associated with experimental treatments.
The eligibility criteria for trials can also be very specific, limiting the pool of potential participants.
Logistical issues such as travel requirements and time commitments can also serve as barriers to participation.
Only 55% of trials recruit their originally specified target sample size, and almost a third of trials receive an extension of some kind.
Detailed recruitment strategies and sharing experiences are crucial for improving recruitment success rates.
The complex and diverse nature of clinical trials, combined with intricate eligibility criteria, often leave physicians and patients overwhelmed. However, these trials play a vital role in advancing medications and treatments, making effective and efficient recruitment strategies crucial.
In this context, precision cancer trial matching has emerged as a powerful solution, leveraging AI and data analytics to identify suitable trials based on patients' unique characteristics.
The world of clinical trials is vast and complex, with over 250,000 trials and hundreds of thousands of genomic variants to consider.
This complexity is particularly pronounced in cancer research, where DNA is the key to precision diagnostics and therapeutics.
Navigating this landscape is a daunting task for physicians and patients alike, with numerous trials and complex eligibility criteria to consider.
Despite the number of active clinical trials exceeding 80,000 globally, only a small percentage of patients are aware of relevant options.
Historically, patient recruitment for cancer trials has been a complex and time-consuming process. The traditional methods of recruitment include clinician referral, patient registries, and outreach through media and public forums.
Despite the significant efforts made, less than 5% of adult cancer patients participate in clinical trials, a statistic that has remained largely unchanged over the years.